Cancer Genome Sequencing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022

Single User License:

Cancer Genome Sequencing Market Global Industry Analysis, Size,

Share, Growth, Trends And Forecast

2014 – 2022

USD 4315.5









Transparency Market Research

State Tower,

90, State Street, Suite 700.

Albany, NY 12207

United States

www.transparencymarketresearch.co

m

sales@transparencymarketresearch.

com

Flat 10% Discount!!

Free Customization as per your requirement

You will get Custom Report at Syndicated Report

price

Report will be delivered with in 15-20 working days

Request Sample

Buy Now

REPORT DESCRIPTION

Over the last few years, the genomic era of cancer studies is developing at a rapid pace fueled by the

emergence of next-generation sequencing technology rendering exquisite resolution and sensitivity.

Frequent alterations in their gross chromosomal structure by means of amplification, deletion and

inversion of their chromosomal structure forms a characteristic feature of cancer genome. These gene

alterations or modifications ultimately lead to cancer onset and progression.

Browse Full Report with TOC @ http://www.transparencymarketresearch.com/cancer-genomesequencing-market.html

Additionally, the gene sequencing for cancer has several advantages over traditional approaches which

include the ability to perform complete gene sequencing in single test including the detecting copy

number alterations, translocations, and exome-wide base substitutions in all related cancer cells. The

reduction in the cost associated with whole genome sequencing and overall time required to perform these

sequencing has drastically reduced in last couple of years. A study published by TheHuffingtonPost.com,

Inc. in 2013 illustrated that five years ago expenses for performing whole genome sequencing were in

millions of dollars which currently can be performed solely for few thousand dollars. Numerous

technological advancements have significantly contributed in advancing the research studies pertaining to

cancer diagnosis and treatment. Despite this the...